Nasdaq 100 E-Mini Mar '24 (NQH24)

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and Wall Street analysts are optimistic about the stock’s outlook.

Despite Medtronic consistently underperforming the broader healthcare sector, Wall Street analysts remain cautiously optimistic about the stock’s outlook.

Despite Boeing's recent underperformance compared to the Dow Jones Industrials Average, Wall Street analysts still remain cautiously optimistic about the stock's prospects.

Despite Chubb Limited consistently outperforming the Nasdaq, Wall Street analysts remain cautiously optimistic about the stock’s outlook.

Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects.

This insider scooped up 100k shares after penny stock ARAY sold off last month.

With a solid product portfolio, brand strength, and a thirst for innovation, these three companies are on the right track.

With the market back in bullish mode for now, it’s a good time to run Barchart’s Bull Call Spread Screener.

June S&P 500 E-Mini futures (ESM24) are trending down -0.31% this morning as market participants geared up for the start of the Federal Reserve’s two-day policy meeting while also awaiting Wednesday’s...

Apple’s (AAPL) latest developer conference emphasized more than just integrating artificial intelligence into its software; it was also a strategic move to boost iPhone sales. With iPhone sales in decline,...